Home » earnings reports » earning report to watch may 1 2012

Monday, April 30, 2012

earning report to watch may 1 2012

earning report to watch may 1 2012, earning forecast, first quarter earnings results report may 1 2012 : This article provides earnings previews on several stocks to consider in anticipation of their earnings reports. Use this list as a potential starting point for your analysis.

Biogen Idec Inc. (BIIB)
Biogen Idec is a global biotechnology company. The company discovers, develops, manufactures and markets therapies for the treatment of neurodegenerative diseases, hemophilia and autoimmune disorders. The company's products include Avonex, Tysabri, Fampyra, Fumaderm and Rituxan.

Biogen Idec has a market cap of $30.044 billion and will report its first quarter earnings results on May 1, 2012, before market open. The first quarter revenues are expected to be $1.31 billion when compared to $1.20 billion for the same quarter last year. Earnings per share for the first quarter are expected to be $1.48 a share from $1.43 a share in the year ago period. Biogen Idec is currently trading around $125.85 with a 52 week range of $83.83 to $130.00.

Pozen Inc. (POZN)
Pozen is a pharmaceutical company focused on transforming medicine. The company has developed Treximet in collaboration with GlaxoSmithKline (GSK).

Pozen has a market cap of $231.1 million and will report its first quarter earnings results on May 1, 2012, before market open. The first quarter revenues are expected to be $1.27 million when compared to $4.46 million for the same quarter last year. Earnings per share for the first quarter are expected to be loss of 25 cents a share from loss of 19 cents a share in the year ago period. Pozen is currently trading around $7.71 with a 52 week range of $2.15 to $7.95.

Impax Laboratories Inc (IPXL)
Impax is a specialty pharmaceutical company. The company is engaged in development, manufacture and marketing of bio-equivalent pharmaceutical products, referred to as generics, in addition to the development of branded products.

Impax has a market cap of $1.555 billion and will report its first quarter earnings results on May 1, 2012, before market open. The first quarter revenues are expected to be $162.96 million when compared to $108.65 million for the same quarter last year. Earnings per share for the first quarter are expected to be 47 cents a share from 24 cents a share in the year ago period. Impax is currently trading around $23.98 with a 52 week range of $14.46 to $28.75.

Ecolab (ECL)
Analysts are expecting Ecolab to report earnings of 48 cents per share, up 6.7% from a year ago when it reported earnings of 45 cents per share. The consensus estimate remains unchanged over the past month, but it has decreased from three months ago when it was 54 cents. For the fiscal year, analysts are projecting earnings of $3.02 per share. Revenue is projected to eclipse the year-earlier total of $1.52 billion by 79.1%, finishing at $2.72 billion for the quarter. For the year, revenue is expected to come in at $11.9 billion.

Analyst Ratings: The majority of analysts (73.3%) rate Ecolab as a buy. This compares favorably to the analyst ratings of its nearest eight competitors, which average 21.7% buys. Analysts have become more optimistic about the stock recently and the number of buy ratings has risen slightly over the past three months.

Emerson Electric (EMR)Report May 1 2012
Wall Street is high on Emerson Electric (EMR), expecting it to report earnings that are up 11% from a year ago when it reports its second quarter earnings on Tuesday, May 1, 2012. The consensus estimate is 81 cents per share, up from earnings of 73 cents per share a year ago, The consensus estimate is down from three months ago when it was 85 cents, but is unchanged over the past month. Analysts are projecting earnings of $3.49 per share for the fiscal year.

Revenue is expected to be $6 billion for the quarter, 2.5% higher than the year-earlier total of $5.85 billion. For the year, revenue is projected to come in at $25.11 billion.

Analyst Ratings: Analysts generally think investors should stand pat on Emerson, with nine of 17 analysts rating it hold. Emerson’s average analyst rating hasn’t changed over the past three months.

Unum Group (UNM)
For the fiscal year, analysts are projecting earnings of $3.15 per share. Revenue is projected to be 1% above the year-earlier total of $2.56 billion at $2.59 billion for the quarter. For the year, revenue is expected to come in at $10.41 billion.

Analyst Ratings: Most analysts think investors should stand pat on Unum, with nine of 14 analysts rating it hold. Analysts have become more cautious about the stock in the last three months.

TECO Energy (TE)
TECO Energy (TE) reports its first quarter earnings on Tuesday, May 1, 2012.The consensus estimate is 25 cents per share, up 4.2% from a year ago when TECO reported earnings of 24 cents per share. Over the past month, the consensus estimate has risen from 24 cents, but it’s the same as the estimate from three months ago. Analysts are expecting earnings of $1.35 per share for the fiscal year.

Analysts look for revenue to decrease 2.4% year-over-year to $776.8 million for the quarter, after being $796.1 million a year ago. For the year, revenue is expected to come in at $3.46 billion.

Analyst Ratings: Most analysts think investors should stand pat on TECO, with 11 of 15 analysts rating it hold. The average analyst rating of the stock has stayed constant from three months prior.

Airlines, Inc. (SAVE)
Airlines, Inc. (SAVE): Provides passenger airline service primarily to leisure travelers and travelers visiting friends and relatives. Market cap at $1.65B, most recent closing price at $23.0.

Earnings to be released on may 1 2012. Performance over the last quarter at 44.63%. Net institutional purchases in the current quarter at 5.5M shares, which represents about 17.89% of the company's float of 30.74M shares.

For the latest updates on the stock market, PRESS CTR + D or visit Stock Market Today For the latest updates PRESS CTR + D or visit Stock Market news Today

Related Post:

Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)